The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants.

Johnson, Leigh F; Myer, Landon; Jamieson, Lise; Meyer-Rath, Gesine; Delany-Moretlwe, Sinead; Joseph Davey, Dvora

Johnson, Leigh F; Myer, Landon; Jamieson, Lise; Meyer-Rath, Gesine; Delany-Moretlwe, Sinead; Joseph Davey, Dvora.

Afiliação

Johnson LF; Centre for Infectious Disease Epidemiology and Research.
Myer L; Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town.
Jamieson L; Health Economics and Epidemiology Research Office, University of Witwatersrand, Johannesburg, South Africa.
Meyer-Rath G; Department of Medical Microbiology, Amsterdam University Medical Centre, Amsterdam, Netherlands.
Delany-Moretlwe S; The South African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Joseph Davey D; Health Economics and Epidemiology Research Office, University of Witwatersrand, Johannesburg, South Africa.

AIDS ; 38(4): 589-594, 2024 Mar 15.

Article em En | MEDLINE | ID: mdl-38016171

Assuntos

Fármacos Anti-HIV; Dicetopiperazinas; Infecções por HIV; Profilaxia Pré-Exposição; Piridonas; Adulto; Gravidez; Lactente; Criança; Humanos; Feminino; Infecções por HIV/epidemiologia; Aleitamento Materno; Fármacos Anti-HIV/uso terapêutico; África do Sul/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridonas / Infecções por HIV / Fármacos Anti-HIV / Dicetopiperazinas / Profilaxia Pré-Exposição Limite: Adult / Child / Female / Humans / Infant / Pregnancy País/Região como assunto: Africa Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google